Osteonecrosis Related to Oral Bisphosphonate Usage: Case Report and Review of Treatment Strategies

Year 2012, Volume: 5 Issue: 1, 45 - 48, 01.03.2012

Erdem Kilic Zeynep Burcin Gonen Alper Alkan

Abstract

Keywords

-

References

• Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115–7.
• Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate- induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567–75.
• Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62: 527–34.
• Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 2007; 18: 1363-70.
• Carey JJ, Palomo L. Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk? Cleve Clin J Medic 2008; 75(12): 871-9.
• Aguirre JI, Altman MK, Vanegas SM, Franz SE, Bassit ACF, Wronski TJ. Effects of alendronate on bone healing after tooth extraction in rats. Oral Diseases 2010; 16: 674–85.
• Allen MR, Burr DB. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008; 66: 987–94.
• Santini D, Vincenzi B, Avvisati G, Dicuonzo G, Salerno A, Denaro V, et al. Pamidronate induces modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 2002; 8: 1080-4.
• Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005; 353: 99-102.
• )American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 2007; 65: 369-76.
• American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc 2006; 137:1144– 50.
• Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:433-41.
• Chiu CT, Chiang WF, Chuang CY, Chang SW. Resolution of Oral Bisphosphonate and Steroid-Related Osteonecrosis of the Jaw- A Serial Case Analysis. J Oral Maxiilofac Surg 2010; 68: 1055-63.
• Carlson ER, Basile JD. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009; 67: 85–95.
• Filleul O, Crompot E, Saussez SJ. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. Cancer Res Clin Oncol 2010; 136:1117–24.
• Hong JW, Nam W, Cha IH, Chung SW, Choi HS, Kim KM, et al. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int 2010; 21: 847–53.
• Romeo U, Del Vecchio A, Palaia G, Tenore G, Visca P,Maggiore C. Bone damage induced by different cutting instruments--an in vitro study. Braz Dent J 2009; 20(2):162-8.